hotspot -WSS

hotspot

author：Wikipedia 2025-09-27 23:53:27 - browse：3548

Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We also discuss the latest news in the life sciences, including a contrarian take on a new obesity treatment, a congressional effort to ban Chinese biotech companies, and how we managed to make 300 episodes of this podcast.

For more on what we cover, here’s the latest on the mifepristone case; here’s where you can find Adam’s newsletter; here’s more on WuXi and Congress; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Gritstone Bio's cancer vaccine test, and more on Novartis' deal

WSS

An innovative path out of biotech’s “valley of death”

CDC overhauls leadership of center that led response to Covid

Cano Health’s bankruptcy is a warning for Medicare Advantage

Newly revealed memo details efforts to keep Trump in power following election loss

Some of the ways extreme heat will change life as we know it

GOP presidential candidates start declaring their loyalty

entertainment

hotspot

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

BioMarin wins approval for gene therapy to treat hemophilia A

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

DIEP, the 'gold standard' of breast reconstruction, is under threat

Listen: Your guide to Wegovy's blockbuster heart study

Psychedelics group wrestles with new pharma identity

Genentech weighs delaying cancer therapy after drug pricing law

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why CTE doesn’t keep Americans from enjoying the Super Bowl

focus

Newly revealed memo details efforts to keep Trump in power following election loss

The history of OxyContin, told through Purdue Pharma documents

A single Democrat is willing to weaken Medicare negotiation power

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

TB outbreak tied to bone grafts underscores testing shortcomings

The perfect storm of weather conditions that led to the devastating wildfires in Maui

focus

Wikipedia

focus

hotspot